South America Molecular Biology Enzymes, Kits, and Reagents Market to Grow at a CAGR of 16.1% to reach US$ 1,167.37 million Million from 2021 to 2028

The molecular biology enzymes, kits, and reagents market in SAM is expected to grow from US$ 409.79 million in 2021 to US$ 1,167.37 million by 2028; it is estimated to grow at a CAGR of 16.1% from 2021 to 2028.

Brazil and Argentina are major economies in SAM. Molecular diagnostics getting acceptance is the major factor driving the growth of the SAM molecular biology enzymes, kits, and reagents market. Increased adoption of molecular diagnostics procedures for detecting infectious diseases, coupled with advent of new cancer diagnostic solutions, is likely to support the molecular biology enzymes, kits, and reagents market growth during the forecast period. Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA. The irregularities such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions lead to various diseases, including infectious diseases, cancer, viral disease, and sexually transmitted diseases (STDs).

SAM has been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, and Colombia. The COVID-19 outbreak resulted in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor by 45 million and the extremely poor by 28 million. The increasing incidence supports the growth of the market. The pharmaceutical & biotechnology invested in R&D for the new molecule entity. The pandemic as no impact on R&D process, due to pandemic R&D activity increase to find better medicines to cure the life-threatening disease. These factors have had a high impact on the SAM molecular biology enzymes, kits & reagents market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM molecular biology enzymes, kits, and reagents market. The SAM molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.

SAM Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

SAM Molecular Biology Enzymes, Kits, and Reagents Market – By Product

• Enzymes
  • Polymerases
  • Ligases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Restriction Endonuclease
  • Other
• Kits and Reagents

SAM Molecular Biology Enzymes, Kits, and Reagents Market – By Application

• Epigenetics
• Sequencing
• Synthetic Biology
• Polymerase Chain Reaction
• Other

SAM Molecular Biology Enzymes, Kits, and Reagents Market – By End User

• Biotechnological and Pharmaceutical Companies
• Hospitals and Diagnostic Centres
• Academic and Research Institutes

SAM Molecular Biology Enzymes, Kits, and Reagents Market, by Country

• Brazil
• Argentina  
• Rest of SAM

SAM Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned

• Agilent Technologies, Inc.
• F. HOFFMANN-LA ROCHE LTD
• Illumina, Inc.
• Merck KGAA
• MERIDIAN BIOSCIENCE, INC
• Promega Corporation
• Qiagen
• THERMO FISHER SCIENTIFIC INC

South America Molecular Biology Enzymes, Kits, and Reagents Market Report Scope